Thirty-one canine cutaneous masses, diagnosed as mast cell tumors (MCT) by histopathologic analysis, were used to evaluate the immunohistochemical pattern of expression of KIT protein (CD117), a type III tyrosine kinase protein involved in mast cell growth and differentiation. Lesions were graded as I (well differentiated), II (intermediate differentiation), or III (poorly differentiated) according to the following morphologic features: invasiveness, cellularity and cellular morphology, mitotic index, and stromal reaction. Immunohistochemical KIT expression was compared with histologic grade and some histomorphologic features (cell differentiation and nuclear grade) evaluated separately. A possible predictive role of biologic behavior in MCTs for KIT expression was also investigated. Immunohistochemical analysis revealed three different patterns of KIT expression: a cytoplasmic diffuse pattern, a membranous pattern with immunostaining located on the cell surface, and a cytoplasmic perinuclear pattern, where KIT expression was detected in the cytoplasm of the neoplastic mast cells, close to the nucleus. Statistical analysis showed a close relationship between different KIT immunohistochemical patterns and histologic grade (P Ͻ 0.00000), cell differentiation (P Ͻ 0.00000), and nuclear grade (P Ͻ 0.0024). According to Kaplan-Meier-estimated survival curves compared by survival analysis, KIT expression was significantly associated with survival time (P ϭ 0.037) but not cancer-free interval (P ϭ 0.50). Similar to other well-known histomorphological features, KIT expression is a useful parameter of malignancy in cutaneous MCTs. KIT expression also predicted the biological behavior of the tumors in this study.
Introduction
Mast cell tumors (MCT) are one of the most common cutaneous tumors in the dog, accounting for 7-21% of all canine skin tumors and 11-27% of all malignant canine skin tumors. 14 The biological behavior of MCT is highly variable; some tumors are benign whereas others have aggressive growth and metastasize. 3, 28 Attempts have been made to predict the biologic behavior of these tumors using criteria such as clinical stage, 27 growth rate, 3 proliferative activity, 1, 4, 22 and histologic grade. 3, 16 Histologic grade appears to be the most consistently predictive parameter and is mostly based on the grading system proposed by Patnaik, 17 where nuclear morphology and differentiation of neoplastic cells are primary considerations.
The c-kit is a protooncogene that encodes for KIT (CD117), a type III tyrosine kinase protein that is the receptor for stem cell factor (SCF), a cytokine stimulating mast cell growth and differentiation also known as mast cell growth factor. 8 The receptor consists of an extracellular domain of 5 immunoglobulin-like folds From and an intracellular kinase domain separated by transmembrane and juxtamembrane domains. 18, 29 KIT is expressed by mast cells and mast cell progenitors, germ cells, and the interstitial cells of Cajal, the pacemaker cells of the gastrointestinal tract. 8, 29 Mutations in tyrosine kinase receptor have been documented in different human mast cell disorders such as urticaria pigmentosa or aggressive mastocytosis 12, 15 and in a human mast cell leukemia cell line and gastrointestinal stromal tumors (GISTs). 6, 9, 11 Different abnormalities (point mutations, deletions, and duplications) have been identified in the juxtamembrane domain of c-kit in canine MCTs and MCT cell lines 10, 13 and a close correlation was found between the presence of a mutation and tumor aggressiveness. 30 Many of these mutations result in a constitutive activation of c-kit, and they seem to be implicated in both the development and progression of canine mast cell neoplasms. 10, 13, 20 The aim of this study was to evaluate the immunohistochemical pattern of KIT protein expression in canine cutaneous MCTs and to correlate this expression with histologic grade and some histomorphologic features evaluated separately. A possible predictive role of KIT expression on the biologic behavior of MCTs was also investigated.
Materials and methods
Specimens of primary cutaneous MCTs from 31 dogs of different ages, breeds, and sexes, submitted to the Depart- I  I  II  II  II  I  I  III  III  II   1  1  2  1  1  1  1  3  3  2   T  T  I  I  I  T  I  A  A  I  11  12  13  14  15  16  17  18 III  I  II  I  I  II  I  I  II  I   3  1  2  1  1  2  1  1  2  1   A  T  I  A  T  I  I  T  A  I  21  22  23  24  25 Table 1 ). Twentyeight dogs were followed until relapse, death, or for at least 12 mo after surgery. Follow-up data were expressed as cancer-free interval (CFI) (the interval between surgery and evidence of local recurrence or metastasis) and survival time (ST) (the interval between surgery and death because of the tumor, spontaneous or by euthanasia). Three dogs were lost to follow-up. Follow-up information was obtained by means of a questionnaire sent to each referring veterinarian. The questionnaire requested information on breed, sex, and age of the dog, interval in weeks between first observation and removal of the tumor, tumor location, if single or multiple, additional treatment after surgery, date of recurrence or metastasis (or both), and date and cause of death. Formalinfixed samples were paraffin embedded, routinely processed, and histologic diagnoses were made on hematoxylin-eosin and toluidine blue-stained slides. Each tumor was graded by 2 examiners (GS and RP) according to the criteria proposed by Patnaik et al. 17 into well, moderately, and poorly differentiated (grades I, II, and III). These criteria included the following histomorphologic features: extent of involvement or invasiveness, cellular morphology, size of cytoplasmic granules, mitotic activity, and stromal reaction. Cellular differentiation and nuclear morphology were used to define the histologic grade and also as individually evaluated parameters. Cellular differentiation was graded as grade 1, with monomorphic and well-granulated mast cells, grade 2, with moderate anisocytosis and cytoplasmic granularity, and grade 3, with marked anisocytosis and poorly granulated cytoplasm. Nuclear morphology was expressed as nuclear grade and classified as follows: ''typical,'' with nuclei showing monomorphism and a condensed chromatin pattern; ''intermediate,'' with nuclei showing moderate pleomorphism, an irregular chromatin pattern and single prominent nucleoli; and ''atypical,'' with nuclei showing marked pleomorphism and large nucleoli, which were occasionally multiple. Immunohistochemical examination. For each case, a 4m-thick section was stained by the avidin-biotin-peroxidase method. The sections were dewaxed in solvent plus a and rehydrated in graded alcohols. Endogenous peroxidase was blocked by means of 0.3% hydrogen peroxide for 20 min. Sections were then rinsed in Tris buffer, immersed in citrate buffer (2.1 g citric acid monohydrate/liter distilled water), pH 6.0, and incubated respectively for 1 period of 5 min and 5 periods of 2 min and 30 sec each in a microwave oven at 750 W. After microwave irradiation, sections were allowed to cool to room temprature (approximately 20 min). The tissue sections were incubated overnight at 4ЊC in a covered humidity chamber with the primary antibody (polyclonal rabbit anti-human KIT protein-CD117) a at a 1:500 dilution in phosphate-buffered saline (PBS). This step was followed by incubation with the secondary antibody (antirabbit immunoglobulin-G conjugated with biotin) b for 30 min at room temperature and then with the streptavidinperoxidase complex a for 25 min at room temperature. The reaction was developed with diaminobenzidine for 12 min, followed by immediate rinsing in PBS, then in running tap water, counterstained with hematoxylin, dehydrated, and mounted using dibutyl phthalate-xylene. In negative control sections, the primary antibody was substituted by PBS buffer. As a positive tissue control, normal canine cerebellum was used, where there is positive labeling on Purkinje cells.
Statistical analysis
Statistical analyses were performed according to previously established criteria. 5 Correlation between KIT pattern and histologic grade, nuclear grade, and cellular differentiation was investigated by Pearson method and tested for significance by the chi-square test using CSS statistica software. c A P Ͻ 0.05 level of confidence was considered significant. The relationship between outcome (expressed as CFI and ST) and histologic grade, nuclear grade, cell differentiation, and KIT pattern was tested by the Kaplan-Meier curves and compared by survival analysis. A conventional 5% level of significance was used to define statistical significance.
Results
Details of the 31 dogs with MCTs together with the results of the histologic grade, cellular differentiation, and nuclear grade for tumors included in this study are given in Table 1 . According to the Patnaik grade, 17 48% of tumors (15 out of 31) were graded I (well differentiated), 36% (11 out of 31) were graded II (moderately differentiated), and 16% (5 out of 31) were graded III (poorly differentiated). According to nuclear morphology (nuclear grade), 29% of the tumors (9 out of 31) were classified as typical, 42% (13 out of 31) as intermediate, and 29% (9 out of 31) as atypical. According to cell differentiation, 58% (18 out of 31) had grade 1, 25% (8 out 31) had grade 2, and 16% (5 out of 31) had grade 3. At follow-up, tumors recurred in 9 dogs (29%), whereas 6 dogs (19%) died or were euthanized as a consequence of the tumor. Among the prognostic histopathologic variables considered (histologic grade, nuclear grade, and cell differentiation), only histologic grade and cell differentiation showed a significant correlation with ST (P Ͻ 0.0046 and P Ͻ 0.050, respectively) ( Figs. 1, 2) but not with CFI (P Ͻ 0.07 and P Ͻ 0.49, respectively).
Immunohistochemical reactivity of KIT protein. Immunohistochemical specificity of antibody for CD117 (KIT) protein was confirmed in the tissue sections of normal canine cerebellum which expressed positive perinuclear labeling of Purkinje cells and adjacent layer as previously described. 11 Immunohistochemical analysis of the MCTs revealed a positive granular labeling of mast cells, whereas no positive reaction was evident in melanocytes, epidermal structures, or other dermal cells. Different location patterns of KIT expression were recognizable: a diffuse pattern (Fig. 3) where mast cells showed diffuse KIT expression throughout the cytoplasm; a ''surface-associated'' or membranous pattern with immunopositivity located in the cell membrane (Fig. 4) ; and a cytoplasmic perinuclear pattern where KIT expression was detected in the cytoplasm of the neoplastic mast cells, close to the nucleus (Fig. 5 ). Fifty-five percent of the tumors (17 out of 31) showed a cytoplasmic diffuse pattern; 13% (4 out of 31) had a membranous pattern whereas 16% (5 out of 31) had a cytoplasmic perinuclear staining. Mixed patterns were also detected in some cases where variable proportions of cells with different patterns were recognizable: 10% of tumors (3 out of 31) showed mixed cytoplasmic perinuclear and membranous patterns whereas 6% (2 out of 31) had mixed membranous and cytoplasmic diffuse patterns.
Correlation of KIT expression with histologic grade. The relationship between KIT expression and histologic grade of malignancy is shown in Fig. 6 . Thirteen of the 15 grade I tumors showed a cytoplasmic diffuse pattern and the remaining 2 had a membranous/diffuse pattern. All the grade III tumors had a cytoplasmic perinuclear pattern, whereas KIT expression was more variable in grade II tumors: 4 out of 11 showed a cy-toplasmic diffuse pattern, 4 a membranous pattern, and 3 a membranous/perinuclear one.
A highly significant correlation (P Ͻ 0.00000) was evident between histologic grade and KIT patterns: 76.5% and 100% of cases with cytoplasmic diffuse and membranous/diffuse patterns, respectively, were classified as grade I tumors; 100% of cases with cytoplasmic perinuclear pattern were grade III tumors, and 100% of cases with membranous and membranous/perinuclear patterns were grade II tumors. Fig. 7 . Fifteen of the 18 grade I tumors showed a cytoplasmic diffuse pattern, 2 had a membranous/diffuse pattern, and 1 a membranous/perinuclear pattern. All grade III tumors had a cytoplasmic perinuclear pattern, whereas 2 out of 8 grade II tumors showed a cytoplasmic diffuse pattern, 4 a membranous pattern, and 2 a membranous/ perinuclear pattern. A highly significant correlation (P Ͻ 0.00000) was also evident between cell differentiation and KIT patterns: 88.2% and 100% of cases with cytoplasmic diffuse and membranous/diffuse patterns, respectively, were classified as grade I tumors; 100% of cases with cytoplasmic perinuclear pattern were grade III tumors; and 100% of cases with membranous and 67% with membranous/perinuclear patterns were grade II tumors.
Correlation of KIT expression with cell differentiation. The relationship between KIT expression and cell differentiation is shown in
Correlation of KIT expression with nuclear grade. The relationship between KIT expression and nuclear grade is shown in Fig. 8 . Out of the 9 tumors with a nuclear grade classified as typical, 6 showed a cytoplasmic diffuse pattern, 2 a membranous/diffuse pattern, and 1 a membranous pattern, whereas in the intermediate group, 10 out of 13 showed a cytoplasmic diffuse pattern, 1 a membranous pattern, and 2 a membranous/perinuclear pattern. Five out of 9 tumors with a nuclear grade classified as atypical revealed a cytoplasmic perinuclear pattern, 2 a membranous pattern, 1 a cytoplasmic diffuse pattern, and 1 a membranous/ perinuclear pattern. A statistically significant correlation (P ϭ 0.0024) was evident between nuclear grade and KIT patterns: 100% of cases with membranous/ diffuse patterns were classified as tumors with a typical nuclear grade, and 100% of cases with cytoplasmic perinuclear pattern were tumors with an atypical nuclear grade; 59% of cases with cytoplasmic diffuse pattern and 67% with membranous/perinuclear patterns were tumors with an intermediate nuclear grade.
KIT expression and follow-up data. Survival analysis was performed comparing the cytoplasmic diffuse and cytoplasmic perinuclear patterns with follow-up data expressed as CFI and ST. It was not possible to perform the survival analysis for other types of KIT pattern because the number of cases in each group was too low. Kaplan-Meier curves revealed a statistically significant difference in ST between groups with different patterns (P Ͻ 0.037) ( Fig. 9 ) but not in CFI (P Ͻ 0.50).
Discussion
In this study, all canine MCTs showed KIT immunohistochemical expression as reported previously. 20 However, unlike previous reports 20 demonstrating an inverse relationship between staining intensity and degree of tumoral differentiation, this study investigated the immunohistochemical pattern of KIT expression, finding a statistically significant correlation with histologic grade. KIT immunohistochemical pattern is a more objective parameter of KIT expression, easier to assess than staining intensity that may be affected by interobserver variability and differences in sample fixation procedures. Furthermore, a major difference from previous reports 20 is that nuclear morphology and degree of cell differentiation were closely correlated to KIT immunohistochemical pattern, even when evaluated individually. Mast cells show distinctive membranous and cytoplasmic KIT labeling. 8 A similar staining is seen in mast cell disorders and can be used to identify MCTs in bone marrow, skin, lymph nodes, and solid organs. 2, 8, 16, 20, 23 A cytoplasmic diffuse pattern was closely associated with grade I tumors, generally considered clinically benign, whereas the cytoplasmic perinuclear pattern was expressed only by grade III MCTs. Therefore, this KIT pattern may be considered specific for grade III MCTs. Being the most aggressive of the 3 grades, 17 these tumors need a prompt, accurate diagnosis. KIT is an immunohistochemical marker particularly useful in the diagnosis of canine grade III MCTs that may be sometimes difficult to identify because of their variable histologic aspect.
Survival data analysis demonstrated a less-favorable prognosis for cases with a cytoplasmic perinuclear pattern than for those with a cytoplasmic diffuse pattern, showing a close relationship between this type of KIT expression and aggressive tumor behavior. In addition to its diagnostic utility, evaluation of immunohistochemical KIT expression in dogs with MCTs is a prognostic aid to identify patients at high risk for tumorrelated death for which a more aggressive postsurgical therapy may be instituted.
Lastly, grade II tumors showed a more heterogeneous KIT expression: a membranous pattern was found only in grade II tumors, 11 but some grade II tumors also showed cytoplasmic diffuse and mixed (membranous/perinuclear) patterns. This finding explains why histopathologic features of grade II tumors and also survival rates for dogs with grade II MCT vary widely. 1, 3, 4 The classification proposed by Patnaik 17 is based on subjective histopathologic parameters (such as invasiveness, cellular morphology, and mitotic index) that often prove inconsistent in evaluating borderline cases 22 and may have reproducibility problems leading to discordance even among experienced pathologists. 1, 21 Similar results were obtained when KIT expression was correlated to cases classified according the different grades of cell differentiation. KIT is the receptor for SCF, also known as mast cell growth factor, which plays a critical role in mast cell development and differentiation. Interactions between SCF and KIT lead hematopoietic progenitors to develop into mast cells. KIT signaling is required for the differentiation and maturation of mast cells in vivo, chemotaxis, survival, and proliferation of mast cells. 7, 24 KIT immunohistochemical expression encountered in all the MCTs in this study, irrespective of the degree of cell differentiation, indicates that the expression of this growth-promoting cytokine receptor is maintained in malignant canine mast cells. However, different immunohistochemical patterns of KIT expression result from a functional dysregulation of the receptor. Mutations in different domains of the c-kit gene have been found in human patients with mastocytosis, leukemia, and GISTs and also in canine MCTs. c-kit point mutations were identified in 3 lines of malignant mast cells 6, 25, 26 and, more recently, in the juxtamembrane region of c-kit in spontaneous canine MCTs. Tandem duplications affect exon 11, exon 12, and intron 11. 10 Point mutations and small deletions have been disclosed in exon 11, corresponding to the juxtamembrane region of canine c-kit in canine MCTs. 13 These mutations induced constitutive phosphorylation of KIT and implicated c-kit in the pathogenesis of canine MCT. 13 It is now clear that dysregulation of KIT function contributes to the induction or progression of neoplastic mast cell disease also in dogs. Molecular abnormalities in the c-kit gene of MCTs are closely related to the grade of MCT differentiation. 19, 21 A significantly higher percentage of intron 11 deletion was found in moderately and poorly differentiated MCTs than in well-differentiated MCTs, 19 whereas juxtamembrane mutations (duplications and deletions) were seen in grade II and III tumors and no mutation was found in any of the grade I tumors tested. 31 Further studies will clarify the relationship between mutations in the kit-encoding gene and the different patterns of immunohistochemical KIT expression.
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